APX‑115A, a pan‑NADPH oxidase inhibitor, reduces the degree and incidence rate of dry eye in the STZ‑induced diabetic rat model

Dye eye disease (DED) is a common ocular disorder in patients with diabetes. It has been reported that APX-115A, a pan-nicotinamide adenine dinucleotide phosphate (NAPDH) oxidase inhibitor, has an apoptosis-inducing effect on Epstein-Barr virus-infected retinal epithelial cells, but its effects in D...

Descripción completa

Detalles Bibliográficos
Autores principales: Noh, Min Hye, Lee, Dong Kun, Kim, Yeong Seok, Kim, Hye Young, Moon, Sung Hwan, Han, Sang Youb, Hur, Dae Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119744/
https://www.ncbi.nlm.nih.gov/pubmed/37090081
http://dx.doi.org/10.3892/etm.2023.11893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119744/
https://www.ncbi.nlm.nih.gov/pubmed/37090081
http://dx.doi.org/10.3892/etm.2023.11893

Ejemplares similares